The Coronavirus Outbreak

The actual number who resign rather than get the vaccine is much smaller than the survey data suggest

Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

You can listen to all past episodes here.

Pfizer expects to have safety and efficacy data on five- to 11-year-olds by the end of the month, but federal authorities must still review it

The risk of severe disease dropped by factor of almost 20 in people over 60—but some dispute the benefits of offering an additional dose

Fewer than 0.5 percent of vaccine doses have been distributed to people living in low-income countries

Florida governor Ron DeSantis and politicians in Texas say research does not support mask mandates. Many studies show they are wrong

Cases peaked, then fell, then rose again. “It is so much worse this time”

The plan includes vaccine mandates for federal workers and those at companies with 100 or more employees, but some experts say it doesn’t go far enough

Innate immunity might be the key to why children have fared better with the virus. But the Delta variant poses fresh unknowns

Biochemist Katalin Karikó and her colleague Drew Weissman were recently awarded a $3-million Breakthrough Prize for their work

Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

You can listen to all past episodes here.

Self-targeting antibodies attack part of the immune system that plays a key role in fighting infection